Oncologix Tech
OCLG · OTC
$0.00−$0.0001 (−99.00%)TodayMarket closed ·
Prev close $0.0001
Key indicators
OCLG profitability and balance sheet ratios
EPS -$0.0022 in May 2015, against -$0.0021 a year earlier.
| Period | EPS |
|---|---|
| Aug 2013 | -$0.0066 |
| Nov 2013 | -$0.0024 |
| Feb 2014 | -$0.0049 |
| May 2014 | -$0.0021 |
| Aug 2014 | -$0.002 |
| Nov 2014 | -$0.0033 |
| Feb 2015 | -$0.0029 |
| May 2015 | -$0.0022 |
Income statement
No financial statements are reported for Oncologix Tech.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Nov 2014 | Feb 2015 | May 2015 |
|---|---|---|---|
| Total assets | $3.6M | $3.6M | $3.9M |
| Total liabilities | $4.6M | $4.7M | $5.0M |
| Shareholder equity | −$1.0M | −$1.1M | −$1.2M |
| Cash and short-term investments | $0.1M | $0.0M | $0.1M |
| Total debt | $3.1M | $3.1M | $3.3M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.